Germany’s Max Planck Society has signed an agreement with Pohang University of Science and Technology in South Korea, to set up two centres devoted to Attosecond Science and Complex Phase Materials.
JADO Technologies, a spin-out from the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, is developing small molecules that target cell membrane receptors, opening up a potential new avenue for drug delivery.